Physical activity and quality of life in patients with pulmonary hypertension.
作者信息
Cascino Thomas M, McLaughlin Vallerie V, Richardson Caroline R, Behbahani-Nejad Nilofar, Moles Victor M, Visovatti Scott H, Jackson Elizabeth A
机构信息
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
出版信息
Eur Respir J. 2019 Jun 20;53(6). doi: 10.1183/13993003.00028-2019. Print 2019 Jun.
Abstract
摘要
相似文献
1
Physical activity and quality of life in patients with pulmonary hypertension.
Eur Respir J. 2019 Jun 20;53(6). doi: 10.1183/13993003.00028-2019. Print 2019 Jun.
2
Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study.
Heart. 2017 Apr;103(8):592-598. doi: 10.1136/heartjnl-2016-309852. Epub 2017 Jan 18.
3
The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2016 Jun;13(6):842-9. doi: 10.1513/AnnalsATS.201512-824OC.
4
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.
Circulation. 2006 Oct 3;114(14):1482-9. doi: 10.1161/CIRCULATIONAHA.106.618397. Epub 2006 Sep 18.
5
Evidence on Exercise Training in Pulmonary Hypertension.
Adv Exp Med Biol. 2017;1000:153-172. doi: 10.1007/978-981-10-4304-8_10.
6
Respiratory muscle strength in patients with pulmonary hypertension: The relationship with exercise capacity, physical activity level, and quality of life.
Clin Respir J. 2018 Feb;12(2):699-705. doi: 10.1111/crj.12582. Epub 2016 Dec 9.
7
Exercise training in pulmonary hypertension: implications for the evaluation of drug trials.
Circulation. 2006 Oct 3;114(14):1448-9. doi: 10.1161/CIRCULATIONAHA.106.649079.
8
Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH).
BMC Pulm Med. 2018 Mar 1;18(1):40. doi: 10.1186/s12890-018-0586-8.
9
The benefit of exercise training in pulmonary hypertension: a clinical review.
Intern Med J. 2017 Apr;47(4):361-369. doi: 10.1111/imj.13159.
10
Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis.
Vasc Med. 2017 Feb;22(1):37-43. doi: 10.1177/1358863X16670250. Epub 2016 Oct 5.
引用本文的文献
1
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01205-2024. Print 2024 Oct.
2
Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension.
Pulm Circ. 2023 Sep 10;13(3):e12285. doi: 10.1002/pul2.12285. eCollection 2023 Jul.
3
Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension.
Pulm Circ. 2023 Aug 7;13(3):e12271. doi: 10.1002/pul2.12271. eCollection 2023 Jul.
4
Impact of patient characteristics and perceived barriers on referral to exercise rehabilitation among patients with pulmonary hypertension in the United States.
Pulm Circ. 2020 Dec 8;10(4):2045894020974926. doi: 10.1177/2045894020974926. eCollection 2020 Oct-Dec.
本文引用的文献
1
The importance of patient perspectives in pulmonary hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01919-2018. Print 2019 Jan.
2
Update on pulmonary arterial hypertension research: proceedings from a meeting of experts.
Curr Med Res Opin. 2018 Feb;34(2):263-273. doi: 10.1080/03007995.2017.1404974. Epub 2017 Dec 22.
3
The role of an activity monitor in the objective evaluation of patients with pulmonary hypertension.
Clin Respir J. 2018 Jan;12(1):119-125. doi: 10.1111/crj.12495. Epub 2016 May 23.
4
Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
Chest. 2016 Jul;150(1):46-56. doi: 10.1016/j.chest.2016.02.633. Epub 2016 Feb 15.
5
Pulmonary arterial hypertension: the burden of disease and impact on quality of life.
Eur Respir Rev. 2015 Dec;24(138):621-9. doi: 10.1183/16000617.0063-2015.
6
Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2016 Jan;13(1):31-9. doi: 10.1513/AnnalsATS.201412-572OC.
7
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
8
Six-minute walk test in pulmonary arterial hypertension.
Anatol J Cardiol. 2015 Mar;15(3):249-54. doi: 10.5152/akd.2015.5834.
9
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension.
Eur Respir J. 2014 Apr;43(4):1106-13. doi: 10.1183/09031936.00127113. Epub 2013 Nov 14.
10
Has the 6-min walk distance run its course?
Chest. 2012 Dec;142(6):1363-1365. doi: 10.1378/chest.12-1110.
Zotero 插件